MedTrace Logo

Effectiveness of a Video and Mobile App in Breast Cancer Screening Awareness

NCT07059897 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-07-11

No results posted yet for this study

Summary

Introduction: Breast cancer is the most common type of cancer in women in the worldandinTurkey. It also ranks first in cancer-related deaths in women. Lack of awareness about thedisease, lack of information, late diagnosis and inadequate medical facilities cause anincreasein breast cancer incidence and mortality. Objective: To evaluate the effectiveness of a video and mobile phone application preparedtoraise awareness and turn breast cancerscreening into behavior in women aged 40-69 who do not have breast cancer symptoms.

Method: A quasi-experimental study based on design and comparison of pre test, midtest andpost test results of women in a single group. Data were collected via an online surveyandGoogle Play Store (to download the mobile phone application) between May 2023 andJanuary2024. The study was completed with 90 women. Data were collected using an individual information form, Breast Cancer Screening Program information test, animation video, Breast Cancer Screening Warning Program (MEKTUP) mobile phone application, and research evaluation survey.

Conditions

  • Breast Cancer Awareness

Interventions

BEHAVIORAL

Animation video and mobile phone application

An animation video scenario and MEKTUP mobile phone application were prepared by the researchers in light of the literature, in line with the "National Breast Cancer Screening Program" and by taking expert opinions.

Sponsors & Collaborators

  • Istanbul University - Cerrahpasa

    collaborator OTHER

  • Özlem BEKDEMİR AK

    lead OTHER

Principal Investigators

  • Nuran GENÇTÜRK Associate Professor · İstanbul University-Cerrahpasa

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
69 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2023-05-01
Completion
2024-05-29

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07059897 on ClinicalTrials.gov